Background Data
Acute fluid resuscitation after trauma-hemorrhage restores but does not maintain the depressed hepatocellular function and cardiac output.
Methods
Male Sprague-Dawley rats underwent a 5-cm laparotomy (i.e., trauma was induced) and were bled to and maintained at a mean arterial pressure of 40 mmHg until 40% of maximal bleed-out volume was returned in the form of Ringer's lactate (RL). The animals were acutely resuscitated with RL using 4 times the volume of maximum bleed-out over 60 minutes, followed by chronic resuscitation of 0, 5, or 10 mLUkg/hr RL for 20 hours. Hepatocellular function was determined by an in vivo indocyanine green clearance technique. Hepatic microvascular blood flow was assessed by laser Doppler flowmetry. Plasma levels of interleukin-6 (IL-6) were determined by bioassay.
Results
Chronic resuscitation with 5 mUkg/hr RL, but not with 0 or 10 mLUkg/hr RL, restored cardiac output, hepatocellular function, and hepatic microvascular blood flow at 20 hours after hemorrhage. The regimen above also reduced plasma IL-6 levels.
Conclusion
Because chronic resuscitation with 5 mLUkg/hr RL after trauma-hemorrhage and acute fluid replacement restored hepatocellular function and hepatic microvascular blood flow and decreased plasma levels of IL-6, we propose that chronic fluid resuscitation in addition to acute fluid replacement should be routinely used in experimental studies of traumahemorrhage.
Severe trauma and blood loss continue to be the main cause of death in persons under age 35.1'2 Trauma and hemorrhage are also one of the most neglected serious health hazards in our society.3 Successful treatment of trauma victims who survive the initial injury includes control of ongoing hemorrhage and rapid restoration of intravascular volume to improve tissue perfusion. Clinically, this initial treatment is followed by continued fluid administration according to hemodynamic indices (e.g., cardiac output) and renal function. Depression of cardiac output after hemorrhage results in decreased organ blood flow and microcirculation, cellular dysfunction, and even cell death.4 Furthermore, after trauma or hemorrhage, significant immunologic alterations occur that are characterized by increased release of proinflammatory cytokines (e.g., interleukin-6 [IL-6], tumor necrosis factor [TNF]).s These alterations persist despite acute fluid replacement.5 Although studies have shown that acute fluid resuscitation with Ringer's lactate (RL) immediately after trauma-hemorrhage restores but does not maintain cardiac output6 and hepatocellular function,7 it is unknown whether continued fluid administration after acute resuscitation maintains hemodynamic stability and hepatocellular function. In addition, studies have shown that TNF and IL-6 levels remain elevated 24 hours after trauma-hemorrhage and acute resuscitation.8 However, it is unknown whether chronic resuscitation downregulates plasma IL-6 levels 1 day after the insult.
Therefore, the aim of this study was to determine whether chronic resuscitation after trauma-hemorrhage and acute fluid replacement restores cardiovascular and hepatocellular function and decreases circulating proinflammatory cytokine levels.
MATERIALS AND METHODS Experimental Procedures
A previously described nonheparinized model of trauma-hemorrhage in the rat was used, with minor modifications.67'9 Briefly, male Sprague-Dawley rats (275-325 g) were fasted overnight before the expenrment but allowed water ad libitum. The rats were anesthetized by methoxyflurane inhalation before trauma was induced by a 5-cm midline laparotomy. The abdomen was then closed in layers, and catheters were placed in the right jugular vein at the level of the right atrium (silicone tubing, 0. 
IL-6 Assay
Blood samples were drawn aseptically from the carotid artery and immediately transferred to pyrogen-free microcentrifuge tubes (Sarstedt, Newton, NC) and spun down at 16 ,000 g in a refrigerated (4 C) centrifuge (MicroCentrifuge Model 235C; Fisher Scientific, Livonia, MI). The plasma was aliquoted into pyrogen-free microcentrifuge tubes and immediately frozen (-85 C) until the time of the assay. Plasma samples were diluted 1:15 (plasma:media) in RPMI 1640 (Gibco BRL, Grand Island, NY) containing 10% heat-inactivated fetal calf serum (Biologos, Naperville, IL) and thereafter in threefold serial dilutions, with IL-6 activity determined by assessing the ability of the plasma to induce the proliferation of the 7TD1 B-cell hybridoma. The relative units of cytokine activity per milliliter of plasma were determined by comparing the curves produced from experimental plasma supernatant to standard curves produced from a recombinant human IL-6 standard (200 U/mL, Amgen, Thousand Oaks, CA), according to the methods of Mizel.14 The 7TD1 murine B-cell hybridoma, a gift from Dr. Jacques van Snick (Ludwig Institute of Cancer Research, Brussels, Belgium), was maintained as described by van Snick et al. 15 This bioassay has been routinely used by our laboratory and was previously reported to react in a highly specific manner to IL-6.s Supplementation of this bioassay with murine interleukin-2 through -4, TNF-a, or interferon-y does not induce proliferation of the 7TD1 B-cell hybridoma cytotoxicity. 16 However, these observations do not preclude the possibility that other agents (e.g., glucocorticoid, prostaglandin) may influence these assays. Nevertheless, IL-6 in this bioassay was completely inhibited by the addition of monoclonal IL-6 antibodies. '7 Tissue Water Content Determination At the end of the experiment (20 hours after hemorrhage and acute fluid replacement), small pieces of the heart, lungs, liver, kidney, spleen, small intestine, and skin were excised, weighed, and dried for 24 hours at 95 C. Tissue water content (%, wt/wt) was calculated as (wet wt -dry wt)/(wet wt) x 100.
Statistical Analysis
Results are presented as mean ± standard error of the mean. The data were analyzed with one-way analysis of variance, followed by the Fisher's least significant difference test as a post hoc test for multiple comparison. The differences were considered significant at p < 0.05.
RESULTS

Hemorrhage Parameters
The average time to reach the maximum bleed-out was 47 ± 1 minutes. The average bleed-out volume was 11 ± 0.1 mL per rat (approximately 59% of estimated circulating blood volume18). The time until the end of the hemorrhage was 89 ± 1 minutes. There was no significant difference in these parameters between the three hemorrhaged groups. 
Cardiac Index and Blood Pressure
The cardiac index decreased significantly at 20 hours after the end of acute resuscitation in RLO and RL10 animals compared to sham-operated animals (Fig. 1) . RL5 animals, however, showed no significant decrease compared to shams and a significantly improved cardiac index compared to the RLO group (see Fig. 1 ). On the other hand, MAP decreased significantly in all hemorrhaged groups compared to sham-operated animals immediately, as well as 20 hours after the end of acute resuscitation (Fig. 2) . Despite this, RL5 animals showed significantly higher MAP than RLO animals at 20 hours after acute resuscitation (see Fig. 2 ).
Hepatocellular Function
Vma,, values decreased significantly in RLO and RL1O animals at 20 hours after acute resuscitation compared to sham-operated animals (Fig. 3A) . The RL5 group showed significantly elevated V.a,, values compared to RLO animals, and the values were not significantly different from shams (see Fig. 3A ). Furthermore, Km decreased signifi- (Fig. 3B ).
Hepatic Microvascular Blood Flow
The hepatic microvascular blood flow decreased significantly in RLO and RL1O animals compared to shamoperated animals. The RL5 group showed a higher hepatic microvascular blood flow than did RLO animals, and it was not significantly different from shams (Fig. 4A) .
Plasma IL-6
Plasma IL-6 values increased significantly in RLO animals compared to sham-operated animals. RL5 and RL1O animals showed significantly reduced plasma IL-6 values compared to RLO animals (Fig. 4B ). There was a significant negative linear correlation (r = 0.56) between IL-6 and Vma, values (Fig. 5) . Extensive studies have been conducted concerning optimization of initial fluid resuscitation with various types of fluids.67'21-23 Less attention has been directed to the events that follow successful acute resuscitation after experimental trauma and hemorrhagic shock. Studies indicate that despite successful resuscitation, disturbed organ function may persist for a prolonged time: defects in peripheral blood flow and oxygen use often can be demonstrated. [24] [25] [26] In our laboratory, we have shown that aggressive fluid resuscitation immediately after trauma-hemorrhage restores but does not maintain cardiac output.6 In addition, our studies have indicated that acute resuscitation restores but fails to maintain hepatocellular function.7 However, it is unknown if continued administration of crystalloid can maintain cardiac output and hepatocellular function after hemorrhagic shock and acute resuscitation.
Our data indicate that continued fluid administration (5 mL/kg/hr RL) for 20 hours optimizes cardiac output, hepatic microvascular blood flow, and hepatocellular function. Furthermore, chronic resuscitation reduces IL-6 release. However, despite the improved cardiovascular and hepatocellular function in the group receiving chronic resuscitation with 5 mL/kg/hr RL, the reduced MAP was not restored. This was also associated with edema development, mainly in the skin. The significantly decreased MAP might be due to persistent endothelial dysfunction after hemorrhage, as previously reported from our laboratory. 27 Those studies indicated that the endothelial dysfunction occurs as early as 1.5 hours after hemorrhage and persists despite acute fluid resuscitation." In the present study, MAP remained low even in the group with improved cardiac output. Therefore, it may be possible that chronic crystalloid resuscitation alone does not attenuate the endothelial dysfunction and fails to restore MAP after trauma-hemorrhage. Thus, pharmacologic agents may be necessary to restore MAP under such conditions. Nonetheless, our study clearly demonstrates that chronic resuscitation with 5 mL/kg/hr RL after trauma-hemorrhage and acute resuscitation restores cardiac output and hepatocellular function. We limited this study to 20 hours after hemorrhage because this seems to be a reasonable period of time to expect any salutary or deleterious effects of chronic fluid resuscitation after trauma-hemorrhage. Nonetheless, further studies are required to determine whether chronic resuscitation with 5 mL/kg/hr RL maintains cardiovascular and hepatocellular function for periods longer than 20 hours after hemorrhage and acute fluid replacement. We used the ICG dilution technique to measure cardiac output and the ICG clearance technique to determine hepatocellular function. The ICG clearance technique has been used in different animal models and in the clinical setting to determine hepatocellular function28-31 and has been found to be a specific and extremely sensitive early indicator of hepatocellular dysfunction after various adverse circulatory conditions.12,29 The advantage of using ICG for measuring hepatocellular function is that this dye has no reported toxicity at low doses in humans and rats. It is cleared from the blood exclusively by an energydependent process in the liver, with negligible extrahepatic elimination.32 ICG can be measured in vivo by using a hemoreflectometer, which makes sampling of blood unnecessary.12 The determination of Vma, and Km with three different doses, as described previously, represents the hepatocellular function independent of the hepatic blood flow. 18, 33 Hepatic microvascular blood flow was measured with laser Doppler flowmetry. This method has been shown to correlate well with other techniques (e.g., the radiolabeled microsphere method), despite some limitations, such as the limited depth of the measurement in the tissue. '3 We chose not to give blood for resuscitation. This kept the model simple and simulated the clinical situation in which a patient rejects blood products or blood is not given to avoid the risk of transmitting disease (e.g., AIDS, hepatitis). However, this raises the question of whether hemodilution (and the potential decrease of oxygen delivery) affects organ function after hemorrhagic shock. Re (data not shown). The fact that chronic resuscitation with 5 mL/kg/hr RL improves hepatocellular function and decreases IL-6 release or production suggests that downregulation of this proinflammatory cytokine may be responsible for maintaining hepatocellular function under such conditions. The decreased hematocrit in the hemorrhaged animals does influence the ICG measurements: previous studies indicated that there is a negative correlation between the systemic hematocrit and blood ICG measurements.7 A 50% decrease in the hematocrit increases blood concentrations of ICG by approximately 35%, as measured by in vivo hemoreflectometer versus spectrophotometer.7 Such an effect was taken into account in determining the hepatocellular function in this study.
In summary, we found that chronic resuscitation after trauma-hemorrhage and acute resuscitation with 5 mL/ kg/hr but not 10 mL/kg/hr RL in the absence of blood resuscitation improves cardiac output, hepatocellular function, and microvascular blood flow. Although both rates of chronic resuscitation decrease circulating levels of IL-6, the decreased levels of this cytokine in the RL1O group may be due to dilutional effects. We therefore conclude that careful fluid optimization after trauma-hemorrhage is required for improving cardiovascular and hepatocellular function. Chronic fluid resuscitation should be included in long-term experiments of trauma-hemorrhage.
